ReviewRheumatology international2025
Novel association of chilblains with inflammatory arthritis- series of three cases and review of literature.
Review in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chilblains are well circumscribed erythrocyanotic lesions seen usually on limbs distally and triggered by cold and damp conditions; they can be primary or secondary. Association of SLE and chilblains is well established, and there are also reports of associations with vasculitis and antiphospholipid syndrome. There remain considerable gaps in literature about the management of secondary chilblains. Three studies looking at primary chilblains showed some benefit from corticosteroids, but this was inferior to pentoxifylline and tadalafil. There are no trials in secondary chilblains. Chilblains have not been described in the context of inflammatory arthritis- either Rheumatoid Arthritis or seronegative spondyloarthropathy. We report 3 patients with a combination of chilblains, seronegative inflammatory arthritis and phalangeal bone marrow oedema on MRI scans. These patients presented with joint symptoms alongside chilblains with conclusive evidence of inflammatory arthritis. Immunosuppressive treatment resulted in an excellent clinical response. Literature review did not identify any previous descriptions of chilblains together with inflammatory arthritis, whilst bone marrow oedema has primarily been described in children together with chilblains. This case series provides some support for managing secondary chilblains through immunosuppression such as corticosteroids and disease modifying drugs.
Indexed as
Identifiers
40172580What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.